Clinical trial design for mild-to-moderate community-acquired pneumonia--an industry perspective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 47 Suppl 3, Issue , 2008, Pages

  Echols, Roger M ^a   Tillotson, Glenn S ^a   Song, James X ^a   Tosiello, Robert L ^a  

^a Replidyne Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL PNEUMONIA; CLINICAL TRIAL; COMMUNICABLE DISEASE; HUMAN; METHODOLOGY; REVIEW; STREPTOCOCCUS PNEUMONIA; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 58149218498     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/591399     Document Type: Review

References (48)